Literature DB >> 5335061

Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.

W C Kuzell, L M Seebach, R P Glover, A E Jackman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5335061      PMCID： PMC2453410          DOI： 10.1136/ard.25.Suppl_6.634

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

Review 1.  Gout treatment: what is evidence-based and how do we determine and promote optimized clinical care?

Authors:  Ted R Mikuls; Kenneth G Saag
Journal:  Curr Rheumatol Rep       Date:  2005-06       Impact factor: 4.592

2.  Pyrazolidines in the treatment of gout.

Authors:  W C Kuzell
Journal:  Can Med Assoc J       Date:  1968-11-30       Impact factor: 8.262

Review 3.  Optimizing current treatment of gout.

Authors:  Frances Rees; Michelle Hui; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

4.  Purine and pyrimidine excretion in psoriasis: a comparison with healthy controls during allopurinol therapy.

Authors:  H A Simmonds; A Bowyer
Journal:  Br J Clin Pharmacol       Date:  1974-04       Impact factor: 4.335

Review 5.  Allopurinol for chronic gout.

Authors:  Rakhi Seth; Alison S R Kydd; Rachelle Buchbinder; Claire Bombardier; Christopher J Edwards
Journal:  Cochrane Database Syst Rev       Date:  2014-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.